Market Research Blog

The Micro Computed Tomography Market revenues were estimated at US$ 190.3 Mn in 2021 and is anticipated to grow at a CAGR of 11.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 608.7 Mn. In-Vivo Micro Computed Tomography to Register an Absolute Dollar Opportunity of US$ 346 Mn.

The global prevalence of a variety of ailments has prompted governments to increase their research and development spending. Several healthcare providers are increasing their R&D investment in order to develop more advanced Micro Computed Tomography systems and tools, which will aid market growth throughout the forecast period. Furthermore, increased R&D spending by various companies across a variety of industries is expected to boost demand for Micro Computed Tomography around the world.

Micro-CT scanning renders monochromatic X-rays that are largely parallel with high flux that permits rapid scanning and large datasets. This research also exhibits high spatial resolution, high bone and lung sensitivity, economical price, and short scan time.

The recent COVID-19 pandemic had a significant impact on the market, leading in a decrease in imaging device output as well as delays in micro-CT machine import and export, causing significant economic disruption. Now that the lockdown limitations have been lifted, the market is gradually returning to normalcy.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14773

The COVID-19 outbreak has had a significant impact on the tiny computed tomography market, as imaging device production has reduced. The installation of numerous limitations on a commercial domain, such as a restricted workforce, a temporary prohibition on production units, and imports and exports, has impeded the micro computed tomography market.

Key Takeaways from the Market Study

• Global Micro Computed Tomography Market is expected to reach a market size of US$ 209.9 Mn by 2022.
• The Life Sciences segment, is expected to have the highest CAGR rate of 14.6% during the forecast period.
• United States is expected to remain the most dominant country with absolute dollar growth opportunity of US$ 149.2 Mn.
• The market in Japan is set to experience the highest CAGR of 14.8% during the 2022-2032 forecast period.

“With the evolution of high resolution micro-computed tomography systems, the market is expected to witness significant spurt in the coming decade” comments a Future Market Insights analyst.

Competitive Landscape

The market is fiercely competitive, where key competitors have been using various techniques to boost their growth. Some of the key players in Micro Computed Tomography Market include Bruker Corporation, PerkinElmer, Thermo Fisher Scientific, Zeiss, Neoscan, Sanying Precision Instruments Co. Ltd., North Star Imaging Inc., SCANCO Medical AG, andTESCAN.

• In September 2021, with PerkinElmer’s takeover of BioLegend, a leader in the research arena for immunologists, the Company wanted to expand into fast-growing areas of life science like proteogenomics, recombinant proteins, flow cytometry, multiplex assays, magnetic cell sorting, and bioprocessing.
• In August 2021, Tescan announced the introduction of UniTOM HR, which it claims as the first dynamic micro-CT system in the world with sub-micron resolution, along with 3D non-destructive imaging for static studies and high temporal resolution for continuous 4D dynamic CT research.

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-14773

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Micro Computed Tomography Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals extensive growth in Micro Computed Tomography Market in terms of Product Type (In-Vivo, Ex-Vivo), Application (Life Sciences, Bones, Dentistry, Plants and Food, Material Science, Geology) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Future Market Insights’ Domain Knowledge in Healthcare Division

Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analysed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

For more information, refer to our market research report or contact the PR author.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14773

Market Segments Covered In Micro Computed Tomography Market Analysis

By Product Type:

• In-vivo
• Ex-vivo

By Application:

• Life Sciences
• Bones
• Dentistry
• Plants and Food
• Material Science
• Geology/Oil and Gas Geology

By Region:

• North America
• Latin America
• Europe
• APAC
• MEA

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The Veterinary Endoscopes market revenues were estimated at US$ 245.2 Mn in 2022 and is anticipated to grow at a CAGR of 8.7% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 560.3 Mn.

On of the key factor spurring veterinary endoscopes market growth is increasing pet ownership. According to the European Pet Food Industry 2020 report, Germany, has the highest pet population in Europe. According to the American Pet Products Association’s 2019 to 2020 National Pet Owners Survey, the most popular pet in the United States is a dog. The American Veterinary Medical Association asserts that between 2017 and 2018, 2.8% of U.S. households had pet birds. Ferrets had a population of 0.5 Mn, and rabbits had a population of 2.2 Mn. The U.S. spent an average of US$ 40 annually per household for pet birds. This likely will increase the demand for small animal endoscopes in future.

Due to associated benefits such as real-time image projection on a digital screen and application in complex operations, video endoscopy systems are projected to gain popularity among veterinary endoscopes in the coming years. In case of suspected irregular breathing or nasal discharge, video endoscopy is often performed to check the upper respiratory tract. Video endoscopes can also be used to look into the urethra and bladder, as well as the sinuses in the brain.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14774

Veterinary endoscopes are utilized in a range of diagnostic procedures, including liver or kidney biopsies during laparoscopy and diagnostic samples during otoscopy, therefore market expansion is likely to be supported by increasing demand from diagnostic clinics. Various diagnostic methods are performed to evaluate cases of weight loss, chronic nausea, and chronic diarrhea. Over the next few years, this is projected to propel market expansion.

Key Takeaways from the Market Study

• Global Veterinary Endoscopes market is expected to reach a market size of US$ 560 Mn by 2032.
• In 2022, North America is estimated to contribute more than 35% market revenue.
• Among application, Diagnostics contributes with maximum revenue growing at a CAGR of 9.9%.
• Small animal segment is expected to grow at the highest rate of 8.2% CAGR.
• Going by the country, US is expected to generate largest revenue of US$ 190 Mn by 2032.

Competitive Landscape

A number of regional and global players operate in this market. Some of the key players operating in the market include Steris, MDS Incorporated, Firefly Global, eKuore, and KARL STORZ SE & Co KG. Some of the recent developments of key Veterinary Endoscopes providers are as follows:

• In December 2020, Cantel Medical Corp and CENSIS TECHNOLOGY have announced a new long-term contract to combine Cantel Medical Corp’s premier endoscope reprocessing workflow portfolio with CENSIS’s surgical asset monitoring and instrument monitoring solutions.
• In December 2020, Apollo Endosurgery, Inc., a leader in the field of minimally invasive gastrointestinal and bariatric surgical instruments, announced approval from the U.S. Food and Drug Administration (FDA) for its X-TackTM Endoscopic HeliXTM Tacking System. This system contains sutures primarily designed for use in closing and repairing defects in the lower digestive tract with upper gastrointestinal tract applications.

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-14774

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Veterinary Endoscopes market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals essential insights on the basis of end users across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Future Market Insights’ Domain Knowledge in Healthcare Division

Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analysed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Market Segments Covered in Veterinary Endoscopes Industry Analysis

By Type:

• Rigid
• Flexible
• Other Types

By Animal Type:

• Large Animals
• Small Animals

 Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14774

By Application:

• Surgical/ interventional
• Diagnostic

By Procedure Type:

• Respiratory Endoscopy
• Gastrointestinal tract Endoscopy
• Urinary & genital tract Endoscopy
• Abdominal Endoscopy
• ENT Endoscopy
• Other Procedure Types

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

As per the latest report published by Future Market Insights, a leading Market Research firm, the Surgical Sphincteroplasty Market is valued at US$ 1.5 Bn and is anticipated to reach the valuation of US$ 3.2 Bn by the end of 2032 by growing at a CAGR of 7.4%. The compound annual growth rate for the forecasted period is significantly higher from the historical CAGR of 6.1%. Furthermore, the market is expected to offer an absolute dollar opportunity of US$ 1.6 bn in the upcoming 10 years.

The Non-Surgical segment generated the most revenue in the Global Surgical Sphincteroplasty Market in 2021, rising at a CAGR of 7.2%. The Non-Surgical segment produced the most revenue in the Global Surgical Sphincteroplasty Market in 2021, growing at a higher CAGR of 7.2 than the other segment that year. The geriatric population favors treatments that reverse or stop effects of injury, and the Sacral Nerve Resection treatment earned an excellent success rate by accomplishing this without permanently injuring the nerves that surround it.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14803

Key Takeaways from the Market Study

• The Market is expected to grow at a CAGR of 4% which is significantly higher than its historical CAGR of 6.1%.
• By the end of 2032, the Global market for Surgical Sphincteroplasty will reach the valuation of US$ 3.2 Bn.
• Within the period between 2022 and 2032, the market is expected to offer an absolute dollar opportunity of US$ 1.6 Bn.
• The Non-Surgical segment leads among other segments by growing at a CAGR of 2% while its historical growth was just 6.1% during the period between 2017 and 2021.
• The U.S. market for Surgical Sphincteroplasty constitutes a majority stake of 35% in the global market. It is expected to grow at a CAGR of 2% during the forecasted period of 2022 to 2032.
• The Japanese market is expected to grow at the highest CAGR of 1% followed by China at the forecasted rate of 8.3%.

The COVID-19 pandemic prompted stringent lockdown, shortage of healthcare staffs, cancellation of clinical trials and elective surgical procedures, thus moderately hampering the growth of surgical sphincteroplasty market, comments a Future Market Insights analyst.

Competitive Landscape

The Surgical Sphincteroplasty Market is driven by the market players who are expanding their product portfolios by highly investing in the R&D and product development areas. Government funding, technological breakthroughs, regulatory clearances, mergers and acquisitions, and a diversified product offering have all helped to maintain the environment competitive. The leading companies are expected to gain from new product releases and the expansion of present operations in the untapped international market.

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-14803

The key competitors in the Surgical Sphincteroplasty Market are Medtronic, Hill-Rom Services, Inc., McKesson, B. Braun, Becton, Dickinson and Company, Novo Surgical, Inc., Surgical Holdings, Pelvalon, Salix Pharmaceutical Inc., Johnson & Johnson, etc.

The major developments in the Surgical Sphincteroplasty Market are:

• In December 2021, Baxter International Inc. completed the acquisition of Hillrom for US$ 12.5 Bn to accelerate its vision of transforming the healthcare sector from hospitals to home.
• In November 2021, Walgreens Boots Alliance acquired 30% stake in German GEHE-Alliance Healthcare Joint Venture from McKesson. This will result in takeover of 100% control of GEHE-Alliance Venture by Walgreens Boots Alliance.
• In December 2021, Tissuemed Ltd. was acquired by Becton, Dickinson and Company to make further advancements in its existing product portfolio. It will combine BD’s experience with Tissuemed’s solid base to establish itself as a dominant player across the globe.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Surgical Sphincteroplasty market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Type (Surgical and Non-Surgical), across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Future Market Insights’ Domain Knowledge in Healthcare Division

Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analysed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Market Segments Covered In Surgical Sphincteroplasty Market Analysis

By Type:

• Surgical
  • Direct apposition sphincteroplasty
  • Overlapping sphincteroplasty
• Non-Surgical
  • Sacral nerve stimulation
  • Vaginal balloon inserts
  • Other Non-Surgical

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14803

By Region type:

• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Others
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia
  • Others
• APAC
  • India
  • China
  • Japan
  • South Korea
  • Australia
  • Others
• Other

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

As per the study at FMI, the breast lesion localization market is valued at US$ 325.5 million in 2022 and is expected to reach US$ 554.9 million by 2032, growing at a 5.5% CAGR through 2032.

Rising cases of breast cancer led by increased government spending on the research and development of drugs and services to counter the disease are flourishing in the breast lesbian localization market, enhancing the healthcare structure while spreading awareness about early diagnosis.

Growing chronic diseases like breast cancer and multiple diagnosis methods, including early detection and screening, coupled with it being the most prevalent cancer, are helping the breast lesion localization market gain traction.

Breast cancer’s early detection and screening, and treatment, according to that diagnosis, have gained a good amount of traction in the breast lesion localization market. Breast cancer is the second leading cancer-related death in women worldwide.

The use of cutting-edge technology like artificial intelligence, integrated healthcare platforms, and digital monitors has helped the healthcare and diagnosis sector to evolve and get set up in new regions.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3396

Government programs also promote multiple kinds of diagnosis, treatment, and screening processes that lastly help doctors and patients understand the real-time situation, pushing the demand for breast lesion localization.

High-cost range of these systems, newer, cheaper system alternatives, lower awareness, and incompetent health workers that need to be trained and upskilled are the major restraints for the Breast lesion localization market.

Uncertain FDA approvals, such as nuclear regulatory clearance, along with a shortage of skilled oncologists, are restricting the growth of breast lesion localization.

KEY TAKEAWAYS:

• United States thrives at a CAGR of 3.9% between 2022-2032 and is expected to hold a market revenue of US$ 136 Mn by the end of 2032.
• Increasing breast cancer cases coupled with advanced diagnosis options while upgrading the healthcare system and their integration with latest technology like AI and IOT are fueling the growth in this region.
• Breast Biopsy segment is the largest segment by the usage type and will hold the biggest portion of the market in the forecast period, thriving at CAGR of 3.5% through 2032. The growth of segments is attributed to easy removal and short time span and lower post-surgery impacts than the lumpectomy.
• The UK, being the highest growing market globally, will hold US$ 18.2 Mn by the end of 2032 as it thrives on a promising CAGR of 4.4% between 2022-2032

COMPETITIVE LANDSCAPE:

Some of the breast lesion localization market competitors listed in the FMI’s study on Breast lesion localization market are Hologic Inc, Becton, Dickinson and Company, Merit Medical System, Leica Biosystems, Nussloch GmbH and Argon Medical Devices.

Recent Developments

• Hologic Inc has introduced LOCalizer, the wire-free breast lesion system that is designed to mark and guide non-palpable breast lesions using a miniature. This innovative technology pushes the market and increases the demand for breast lesion localization processes.
• CMerit Oncology has upgraded its scout radar localization that helps in reducing the OR delays and targets the affected tissue and points it out, easing the surgery processes.

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-3396

Key Market Segments Covered in Breast Lesion Localization Devices Industry Research

By Technique:

• Wire Localization
• Non-Wire Localization
• Radar Reflector Localization
• Magnetic seed Localization
• RFID Tag Localization
• Radioisotope Localization

By Application:

• Breast Biopsy
• Breast Lumpectomy

By End User:

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-3396

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The Hospital supplies such as gloves, medical protective equipment etc., are used for maintaining the hygienic environment and to prevent the spread of hospital-acquired infection. These supplies are stocked to examine, diagnose, and treat disease as an effective solution for patient care.
As per Future Market Insights, the global hospital supplies market was valued at over US$ 28.6 Bn in 2021 and is expected to exhibit growth at a CAGR of 3.7% over the forecast period (2022-2032).

According to WHO statistics, approximately 15% of all hospitalized patients suffer from these healthcare-associated infections. Rising prevalence of hospital-acquired infection results in prolonged hospital stay, disability and economic burden. Predisposing factors such as excessive antibiotic consumption and severe illness prevalence will lead to an increase in nosocomial infection rate, which will further push the usage of surgical kits, diagnostic kits and surgical consumables.

The COVID-19 pandemic outbreak escalated the demand for hospital supplies. The prevention of exposure to spread viral infection has fostered the demand for disposable hospital supplies like general disposables (masks, gowns), wound care products, hypodermic products, and sterilization consumables.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14679

The development of the hospital supplies market is reliant on the increasing adoption of sterile products, growing incidence of hospital-acquired infections and rising awareness about safe health and hygiene practices in developing countries.

“Rising awareness regarding medical sterilization and hygiene in developing nations, along with technological advancements hospital supplies will auger well for thr growth in the market,” says an FMI analyst.

Key Takeaways:

•Based on product type, the hypodermic and radiology products segment accounted for 17.6% of the total market in 2021, and demand is expected to increase at a 3.6% CAGR through 2032.

•In terms of end-user, hospitals are expected to register a CAGR of 3.9% in the forthcoming years.

•The U.S. is anticipated to dominate the North America hospital supplies market over the forecast period, accounting for a lion’s share.

•Sales in the Germany hospital supplies market are slated to increase at a 3.5% CAGR over the assessment period.

•Demand in the China hospital supplies market will grow at a 4.1% CAGR in the forthcoming years.

•India will emerge as a lucrative pocket, with demand growing at a 4% CAGR through 2032.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14679

Competition Landscape

The key players in the hospital supplies market are focusing on tapping market potential through entering into strategic mergers & acquisitions agreements. They are also improving their product portfolios to gain a competitive edge in the market. For instance:

•In March 2021, Cardinal Health entered into a partnership with FourKites to improve the tracking of medical supplies and equipment’s along with pharmaceutical products, first aid supplies and personal protective equipment (PPE) kits in hospitals, pharmacies and other healthcare settings across the globe.

•In December 2020, 3M launched its next generation of silicon adhesive tapes, the 2480 3M™ Single coated medical nonwoven tape with silicon adhesive liner. It offers more and secure adhesion, avoids trauma to patient skin and aids a longer wear time. Hence, rising incidents of hazardous situations and chronic disease prevalence will propel market growth in future.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14679

Key Market Segments Covered in Hospital Supplies Industry Research By Product:

•Sterilization Consumables
•Wound Care Products
•Dialysis Products
•Infusion Products
•Hypodermic & Radiology Products
•Intubation & Respiratory Supplies
•Surgical Procedure Kits & Trays
•Blood Management & Diagnostic Supplies
•General Disposable Products

By End User:

•Hospitals
•Ambulatory Surgical Centres
•Clinics
•Diagnostic Centres
•Long Term Care Centres
•Nursing Facilities

By Region:

•North America
•Latin America
•Europe
•South Asia
•East Asia
•Oceania
•The Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to a recent study done by FMI, the geriatric care services market is expected to reach US$ 954 Million by 2032, expanding at a high CAGR of 6%. An expanding geriatric population and the rising awareness regarding the healthcare facilities for senior patients are expected to propel the growth of the geriatric care services market during the forecast period.

The growing demand for home care services for elderly people is a significant factor driving the elderly care products and services market during the forecast period. A growing elderly population coupled with the rising demand of services for individuals suffering from chronic diseases that are above the age of 60 worldwide will further fuel the market growth.

In addition, the presence of a wide range of services within the domain of healthcare has also brought elderly care under the spotlight of attention. The presence of a sound healthcare industry is a prerequisite to the success of a nation’s economy. Considering the aforementioned factors, the global market for geriatric care services is projected to expand at a starry rate in the years to come.

For more insights into the market, request a sample of this report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14708

Key Takeaways from the Market Study

· Global geriatric care services market to be valued at US$ 534 Million by 2022-end

· The U.S to account for the highest value share of US$ 332.5 Million of global market demand for geriatric care services in 2032

· From 2017 to 2021, geriatric care services demand expanded at a CAGR of 10.5%

· By service, the adult day care category constitutes the bulk of geriatric care services market with a CAGR of 6.9%.

· By application, geriatric care services for diabetes to witness maximum growth, at a CAGR of 6.8%

· Global market for geriatric care services to flourish 1.8x from 2022 to 2032

“Governments are taking several initiatives to provide easily accessible and affordable social care services to the elderly population. This, in confluence with the introduction of favorable reimbursement policies, is contributing to the market growth,” remarks an FMI analyst.

Competitive Landscape

Players in the global Geriatric Care Services Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

· In March 2022, Alexion, AstraZeneca’s Rare Disease group, has closed an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal antibody currently in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), an underdiagnosed, systemic condition that leads to progressive heart failure and high rate of fatality within four years from diagnosis.

For Information On The Research Approach Used In The Report, Request TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14708 

· In January 2022, Century Therapeutics and Bristol Myers Squibb announced a research collaboration and license agreement (the “agreement”) to develop and commercialize up to four induced pluripotent stem cell (“iPSC”) derived, engineered natural killer cell (“iNK”) and / or T cell (“iT”) programs for hematologic malignancies and solid tumors. The first two programs include a program in acute myeloid leukemia and a program in multiple myeloma, which could incorporate either the iNK or a gamma delta iT platform.

Key Segments Covered In The Geriatric Care Services Market Report

Geriatric Care Services Market by Service:

• Home Geriatric Care Services
• Adult Geriatric Day Care Service
• Institutional Geriatric Care Services

Geriatric Care Services Market by Payment Source:

• Geriatric Care Services Payment via Public Insurance
• Geriatric Care Services Payment via Private Insurance
• Out-of-Pocket Geriatric Care Services Payment
• Geriatric Care Services Payment via Other Sources

Geriatric Care Services Market by Application:

• Geriatric Care Services for Respiratory Diseases
• Geriatric Care Services for Diabetes
• Geriatric Care Services for Heart Diseases
• Geriatric Care Services for Neurological Diseases
• Geriatric Care Services for Kidney Diseases
• Geriatric Care Services for Cancer
• Geriatric Care Services for Other Applications

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-14708

Geriatric Care Services Market by Region:

• North America Geriatric Care Services Market
• Latin America Geriatric Care Services Market
• Europe Geriatric Care Services Market
• Asia Pacific Geriatric Care Services Market
• Middle East and Africa Geriatric Care Services Market

By Key Players

• Endo Pharmaceuticals Inc.
• Merck & Co. Inc.
• AstraZeneca PLC
• Pfizer Inc.
• Allergan Inc.
• Bristol-Myers Squibb Company
• Regeneron Pharmaceuticals Inc.
• AstraZeneca PLC
• F. Hoffmann-La Roche AG
• Octapharma AG
• Epoch Elder Care
• St Luke’s ElderCare Ltd.
• Korian Group
• ProVita International Medical Center

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The global sleep studies market was valued at over US$ 5.1 Bn in 2021 and is expected to expand at a CAGR of 12.8% over the forecast period.

Polysomnography, also known as a sleep study, is a technique used to diagnose sleep problems. Brain waves, heart rate and respiration, blood oxygen levels, as well as eye and leg movements, are monitored during a sleep study.

Sleep study is usually performed in a lab or clinic, but it can also be performed at home. Sleep studies are used to diagnose narcolepsy, unexplained chronic insomnia, REM sleep behavior disorder, sleep apnea, and other sleep disorders.

Globally, demand for a proper scientific diagnosis for an individual’s sleep disorder is increasing because of the use of proven techniques like brain wave activity, leg movement monitoring, and breathing monitoring.

According to the American Academy of Sleep Medicine (AASM), over 2500 sleep centers are running in the U.S. with their accreditation. This alone signifies the increasing demand among the population.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14730 

With various innovative technologies like portable devices, smartphone applications, and telehealth making their way through, sales will increase at a considerable pace. The expansion of telemedicine may help to alleviate the unmet demand for sleep specialists.

Several illnesses, such as obstructive sleep apnea, have data-driven diagnostic and therapy algorithms that enable effective clinical decision making even in the absence of a physical examination. Unlike many other specialists, sleep physicians rely less on distinct physical examination findings. Telemedicine has the potential to reduce some of the traditional hurdles associated with other devices.

“Increasing adoption of sleep testing devices and rising prevalence of sleep-related disorders will drive the sleep studies market over the forecast period,” says an FMI analyst.

Key Takeaways:

• By testing services, sales in the in-lab testing segment are expected to grow at a CAGR of 9% during the forecast period.
• In terms of indication, obstructive sleep apnea (OSA) accounted for 9% of the total market share in 2021.
• Based on end user, sleep testing centers segment dominated the market by holding a 7% in 2021.
• The U.S. sleep studies market will expand at a 9.7% CAGR over the assessment period.
• Demand in the Germany sleep studies market will grow at a 9.3% CAGR through 2032.
• China will account for a dominant share in the East Asia sleep studies market, with sales growing at a 15.5% CAGR over the forecast period.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14730 

Competition Landscape

Leading players operating in the global sleep studies market are focusing on the launch of new products and services to cater to the growing demand. Key players are also aiming to expand their global presence by opening new service centres to deliver specialized care. For instance:

• In August 2021, ResMed launched the AirSense 11 PAP series, which is a digital health device used in sleep apnea treatment.
• In January 2020, Sleep Dynamics Company expanded its service offering for narcolepsy treatment.

Key Market Segments Covered In Sleep Studies Market Research

By Testing Services:

• Home Sleep Testing
• In-Lab Testing
  • Polysomnography (PSG) Testing
  • CPAP/ BiPAP Titration
  • Split Night Polysomnography
  • Multiple Sleep Latency Test (MSLT)
  • Maintenance of Wakefulness Test (MWT)
  • Epilepsy Monitoring

By Indication:

• Obstructive Sleep Apnoea
• Insomnia
• Restless Leg Syndrome
• Circadian Rhythm Sleeping Disorders
• Narcolepsy
• Rapid eye movement (REM) Sleep Disorders
• Periodic Limb Movement Disorders
• Bruxism

By End User:

• Hospital Settings
• Sleep Testing Centres
• Home Care Settings

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa (MEA)

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-14730

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global sleep studies market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the sleep studies market segment based on testing services (home sleep testing and in-lab testing {polysomnography (PSG) testing, CPAP/ BiPAP titration, split night polysomnography, multiple sleep latency tests (MSLT), maintenance of wakefulness test (MWT) and epilepsy monitoring}), indication (obstructive sleep apnea, insomnia, restless legs syndrome, circadian rhythm sleeping disorders, narcolepsy, rapid eye movement sleep disorders, periodic limb movement disorders and bruxism) and end-user (hospital settings, sleep testing centers and home care settings),  across seven major regions over the globe.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to the latest research by Future Market Insights, the Faecal Extraction System Market will witness growth during 2021-2031. With current researches paving the path for further in depth study which will give minimum discomfort to the victims of this disorder are a positive sign for the faecal extraction systems market.

Being a disruptive system in itself, faecal extraction systems market is in need of  research investments to boost it in the given forecast period to global market.

What is Driving Demand for Faecal Extraction System Market?

Faecal extraction system is a type of device or a tool used to collect stool samples for the purpose of detecting presence of any kind of bacteria, virus, or any other type of parasitic foreign particle present in the stool. Positive identification of these parasites concretes presence of an infection in the body.

According to CDC, there was an increase in hospitalization rate from 44.2% to 59.7% between the years 2001 & 2018. This increase is attributed to increase in inflammatory bowel diseases in the United States as over 3 million individuals were affected from this disease. Also, interestingly all majority of these increase in cases was in individuals with Medicare beneficiaries. This shows the rising awareness among common man about getting tested for IBD  as its increase is becoming imminent cause of hospitalization.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-14040

Stools samples can prove to be potentially important for diagnosing bowel infections, various syndromes which cause poor absorption of the nutrients. This system if executed effectively can help reduce the number of other diagnostic tests which can sometimes prove to be cumbersome and discomforting for the patient. Making it one of the major drivers of this market.

Diverse application of one single stools sample is yet another unique driver for this market. Analysis of a stool from different perspectives like microscopic, immunological, microbiological, chemical, etc. can be done to reach a differential diagnosis. Also, infections occurring from many different type of parasites like bacteria, viruses, etc. can leave their trace in the stool of an individual.

Faecal Extraction System in preventing incontinence-associated dermatitis (IAD)

According to a study published in Australian Critical Care Journal in the year 2021, there is exists a relation between dermatitis caused due to incontinence and the system used to collect a stool sample, connected to continuous low-negative-pressure suction devices.

The researchers suggested that, anal pouch with ongoing low-negative-pressure suction can prove to be effective in collecting stools samples of people critically ill with faecal incontinence. Even though, further more in-depth studies are required, this study has never the less paved as path for future researchers to walk on.

Wherein they can conduct deep research regarding these faecal collection systems with an aim to reduce the overall discomfort of pain as well as reduce the risk of post-colllection inflammations of the skin like dermatitis.

U.S. and Canada Faecal Extraction System Market

With state-of-the-art healthcare as well as ceaseless research projects undertaken in U.S, will make them a dominant market in North American market. Recent development (2018) by a key market player Werfen, wherein, their proprietary faecal extraction device received a clearance by US FDA. ALPCO, which is another important player in the market received a US FDA 510(k) clearance for its Faecal Calprotectin ELISA.

Developments like these showcases the encouragement provided by the authorities in developing novel systems. This will definitely aid U.S in dominating the market as there is an increase in importance of detection, prevention and treatment disease will further boost this market.

Europe Faecal Extraction System Market

The second dominant market in faecal extraction systems will be Europe. Focused research on new product development with the help of testing the product among the masses is actively on the rise in Europe. Buehlmann in collaboration with Telia Company (e-health platform developers) developed a tele-health system specific to inflammatory bowel diseases.

In this application interface, comprehensive IBD patient monitoring, along with constant communication with the healthcare professionals and the patients on the condition of the patient, status of their faecal tests, etc. can be done.  Technological advancements like these are sure to bring in a new perspective into testing and report dispensing in this market.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14040

Who are the key Manufacturing and Supplying Companies in Faecal Extraction System Market?

Key Players:

• ALPCO
• Alpha Laboratories
• bioMérieux SA
• Canvax Biotech
• DRG Instruments GmbH
• Promega Corporation
• Svar Lifescience (CALPRO)
• Arbor Assays
• Werfen
• BUEHLMANN

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Read Related Reports:

https://abkm.tribe.so/post/contrast-media-injectors-market-development-analysis-and-demand-2030-630f3b9c9c32c000380324e6

https://highlowprice.tribe.so/post/contrast-media-injectors-market-growth-and-competitive-dynamics-with-market–630f3b9cb8b1a631a432771f

https://newfriendsoldfriends.tribe.so/post/contrast-media-injectors-market-analysis-company-profiles-competitive-lands–630f3b9d544b846c95009c33

https://dmz.tribe.so/question/contrast-media-injectors-market-overview-growth-share-revenue-and-forecast—630f3b9fb8b1a6c7f5327721

https://tybbhopal.tribe.so/post/contrast-media-injectors-market-fmi-an-esomar-certified-market-research-fir–630f3b9fc91da9273d7b1873

https://articlization.tribe.so/post/contrast-media-injectors-market-share-size-revenue-latest-trends-cagr-statu–630f3ba13f0f12d4a693efde

https://blogbook.tribe.so/post/contrast-media-injectors-market-growth-covid-impact-trends-analysis-report—630f3ba177049038ad05b35e

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs